Cholesteryl hemisuccinate treatment protects rodents from the toxic effects of acetaminophen, adriamycin, carbon tetrachloride, chloroform and galactosamine

Toxicology Letters

Volumn 90, Issue 2-3, 1997, Pages 133-144

  Fariss, Marc W ^a   Lippman, H Robert ^b   Mumaw, Virgil R ^c   Ray, Sidhartha D ^c  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Acetaminophen; Adriamycin ; Carbon tetrachloride; Chloroform; Cholesteryl hemisuccinate; Galactosamine; Hepatotoxicity; Protection

Indexed keywords

4 CHOLESTERYLOXYBUTYRIC ACID; CARBON TETRACHLORIDE; CHLOROFORM; CHOLESTEROL DERIVATIVE; CHOLESTEROL HYDROGEN SUCCINATE; DOXORUBICIN; GALACTOSAMINE; PARACETAMOL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL PROTECTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TOXICITY;

ACETAMINOPHEN; ANIMALS; CARBON TETRACHLORIDE; CHLOROFORM; CHOLESTEROL ESTERS; DOXORUBICIN; GALACTOSAMINE; HEART DISEASES; HEPATITIS, TOXIC; LIVER DISEASES; MALE; MICE; MICE, INBRED ICR; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RODENTIA;

EID: 0031557138     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(96)03837-4     Document Type: Article

References (28)

1. [1] Bach, D., Borochov, N., Wachtel, E.J. and Shinitzky, M. (1995) Cholesteryl hemisuccinate-cholesterol interaction: miscibility properties of the sterols. Chem. Phys. Lipids 76, 123-127.
2. [2] Fariss, M.W., Bryson, K.F., Hylton, E.E., Lippman, H.R., Stubin, C.H. and Zhao, X. (1993) Protection against carbon tetrachloride-induced hepatotoxicity by pretreating rats with the hemisuccinate esters of tocopherol and cholesterol. Environ. Health Perspect. 101, 528-536.
3. [3] Ray, S.D., Mumaw, V.R., Raje, R.R. and Fariss, M.W. (1996) Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J. Pharmacol. Exp. Ther., in press.
4. [4] Fariss, M.W., Fortuna, M.B., Everett, C.K., Smith, J.D., Trent, D.F. and Djuric, Z. (1994) The selective antiproliferative effects of α-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res. 54, 3346-3351.
5. [5] Bergmeyer, H.U., Scheibe, P. and Wahlefeld, A.W. (1978) Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin. Chem. 24, 58-73.
6. [6] Sipes, I.G., Krishna, G. and Gillette, J.R. (1977) Bioactivation of carbon tetrachloride, chloroform, and bromotrichloromethane: role of cytochrome P-450. Life Sci. 20, 1541-1548.
7. [7] Plaa, G. L. (1988) Experimental evaluation of haloalkanes and liver injury. Fundam. Appl. Toxicol. 10, 563-570.
8. [8] Williams, A.T. and Burk, R.F. (1990) Carbon tetrachloride hepatotoxicity: an example of free radical-mediated injury. Semin, Liver Dis. 10, 279-284.
9. [9] Mitchell, J.R., Jollow, D.J., Potter, W.Z., Davis, D.C., Gillette, J.R. and Brodie, B.B. (1973) Acetaminophen-induced hepatic necrosis. 1. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187, 185-194.
10. [10] Potter, W.Z., Davis, D.C., Mitchell, J.R., Jollow, D.J., Gillette, J.R. and Brodie, B.B. (1973) Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 187, 203-209.
11. [11] Hinson, J.A., Pumford, N.R and Roberts, D.W. (1995) Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts. Drug Metab. Rev. 27, 73-92.
12. [12] Powis, G. (1991) Toxicity of free radical forming anticancer agents. In: G. Powis and M.P. Hacker (Eds.). The Toxicity of Anticancer Drugs, Pergamon Press, New York, pp. 106-151.
13. [13] Bachur, N.R., and Gordon, S.L., Gee, M.V. and Kon, H. (1979) NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA 76, 954-957.
14. [14] Davies, K.J.A. and Doroshow, J.H. (1986) Redox cycling of anthracyclines by cardiac mitochondria I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261, 3060-3067.
15. [15] Rosenoff, S.H., Olson, H.M., Young, D.M., Bostick, F. and Young, R.C. (1975) Adriamycin-induced cardiac damage in the mouse: a small animal model of cardiotoxicity. J. Natl. Cancer Inst. 55, 191-194.
16. [16] Rosenoff, S.H., Brooks, E., Bostick, F. and Young R.C. (1975) Alterations of DNA synthesis in cardiac tissue induced by adriamycin in vivo: relationship to fatal toxicity. Biochem. Pharmacol. 24, 1898-1901.
17. [17] Myers, C.E., McGuire, W. and Young, R. (1976) Adriamycin: amerioration of toxicity by α-tocopherol. Cancer Treat. Rep. 60, 961-962.
18. [18] Myers, C.E., McGuire, W.P., Liss, R.H., Ifrim, I., Grotzinger, K. and Young, R.C. (1977) Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197, 165-167.
19. [19] Shinozuka, H., Farber, J.L., Konishi, Y. and Anukarahanonta, T. (1973) D-Galactosamine and acute liver cell injury. Fed. Proc. 32, 1516-1526.
20. [20] Lesch, R., Reutter, W., Keppler, D. and Decker, K. (1970) Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats. Exp. Mol. Pathol. 12, 58-69.
21. [21] Liehr, H., Grun, M., Seelig, H., Seelig, R., Reutter, W. and Heine, W. (1978) On the pathogenesis of galactosamine hepatitis. Indications of extrahepatocellular mechanisms responsible for liver cell death. Virchows Arch. B Cell Pathol. 26, 331-344.
22. [22] Laskin, D.L. and Pendino, K.J. (1995) Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35, 655-77.
23. [23] Cheetham, J.J., Nir, S., Johnson, E., Flanagan, T.D. and Epand, R.M. (1994) The effects of membrane physical properties on the fusion of Sendai virus with human erythrocyte ghosts and liposomes. J. Biol. Chem. 269, 5467-5472.
24. [24] Lai, M., Vail, W.J. and Szoka, F.C. (1985) Acid-and calcium-induced structural changes in phosphatidylethanolamine membranes stabilized by cholesteryl hemisuccinate. Biochemistry 24, 1654-1661.
25. [25] Chelliah, J., Smith, J.D. and Fariss, M.W. (1994) Inhibition of cholinesterase activity by tetrahydroaminoacridine and the hemisuccinate esters of tocopherol and cholesterol. Biochim. Biophys. Acta 1206, 17-26.
26. [26] Lazar, D.F. and Medzihradsky, F. (1992) Altered microviscosity at brain membrane surface induces distinct and reversible inhibition of opioid receptor binding. J. Neurochem. 59, 1233-1240.
27. [27] Sassa, H., Kogure, K., Takaishi, Y. and Terada, H. (1994) Structural basis of potent antiperoxidation activity of the triterpene Celastrol in mitochondria: effect of negative membrane surface charge on lipid peroxidation. Free Rad. Biol. Med. 17, 201-207, 1994.
28. [28] Cervato, B., Viani, P. and Cestaro, B. (1990) Studies on peroxidation processes of model membranes: role of pyrophosphate. Chem. Phys. Lipids 56, 91-99.